Venture fund run by 250+ exited founders

We invest capital.We embed Exited Founders.

We back conscious founders at Seed and Series A, rebuilding human capability, trust, sustainability, and the infrastructure that powers what comes next.

350+
Exited-founder network
$10B+
Portfolio enterprise value
<4yrs
First decacorn backed
01 The Origin

Other funds raise.
Then figure out value.
We did the opposite,
on purpose.

The standard VC playbook: raise a fund, deploy capital, hope the portfolio figures it out. The problem is judgment can’t be hired retroactively. By the time a firm shows up to “add value,” the highest-leverage decisions have already been made.

We did it differently. Before a single LP dollar was committed, we built a structured operating system, matching exited founders to companies at the moments when mistakes are most expensive. We ran it, refined it, and proved it in the market.

2021
The insight

Capital alone doesn't compound. Judgment does.

Barry Stamos and Christopher Staley identify the same pattern across hundreds of portfolio companies: capital alone doesn’t compound. Judgment does. Exited founders are the highest-leverage resource in venture yet almost no one deploys them systematically.

2022 - 2025
The system is built and proven

An operating model, not a thesis deck.

Supernova develops its operating model: structured matching, embedded operators, accountability by design. Hundreds of engagements run. The network grows to 350+ vetted, exited founders. The playbook is written in real companies.

Proven pre-fund
2022
Colossal Biosciences

A decacorn, built on the model.

Supernova’s exited-founder model is activated with Ben Lamm and the Colossal team. The company scales to a $10B valuation in under four years, now a decacorn. One of the most capital-efficient value-creation outcomes in modern science.

$10B valuation
2025
The fund is stood up

LPs aren't funding an experiment.

With a proven system and a documented track record, Supernova formalizes as a fund. LPs are entering a compounding machine that already works.

Fund launch
02 Platform

Judgment is the
new moat.

Capital is abundant. AI lets companies operate lighter. The durable advantage is now the quality of decisions made in real time, with real implications. We put exited founders in the game to solve that problem.

01/Nova AI

NOVA AI: systematic matching

Our proprietary agentic system scores, sources, and matches operator attention on an ongoing basis to support companies proactively.

02/Pattern recognition

Pattern recognition at speed

Our operators have seen the exact problems portfolio companies face. Recognition compresses timelines. What takes others months takes hours.

03/Embedded operators

Embedded exited founders

Founders who have scaled and exited sit alongside your team. They share upside and are invested in the outcome.

04/Network compounding

Judgment compounds

Each exited founder placed, makes the network sharper. Data from 350+ operators feeds back into the system. Returns improve as the fund scales.

03 Proof of model
Our Thesis

When exited founders join forces as investors and operating partners we achieve outsized returns.

The track record is proven.

Colossal Biosciences is the clearest signal. The operating model has been tested across hundreds of companies at every stage, from zebras to unicorns, before the fund was ever raised.

Colossal Biosciences·De-extinction & Biotech
$10B
Series C valuation
<4yrs
First decacorn backed
$200M
Series C raised
They advise me. I advise others. That's the Supernova effect; when exited founders team up, results happen faster.
Ben Lamm
Ben Lamm
6× Exited Founder · CEO & Co-founder, Colossal Biosciences
06 Get in touch

Upload your deck.
See if you qualify in minutes.